{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:31:58Z","timestamp":1786408318176,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/icu.0b013e3283131557","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T03:09:39Z","timestamp":1223953779000},"page":"499-506","source":"Crossref","is-referenced-by-count":56,"title":["The eye and thyroid disease"],"prefix":"10.1097","volume":"19","author":[{"given":"Ajay E","family":"Kuriyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E","family":"Feldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210206","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2006.02.047","article-title":"Pathogenesis of Graves ophthalmopathy: implications for prediction, prevention, and treatment","volume":"142","author":"Garrity","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R2-9-20210206","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/eje.0.1480491","article-title":"Multicenter study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience","volume":"148","author":"Prummel","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"R3-9-20210206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/ICU.0b013e32827038f2","article-title":"Strabismus associated with thyroid eye disease","volume":"18","author":"Schotthoefer","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R4-9-20210206","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02933.x","article-title":"Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission","volume":"67","author":"Eckstein","year":"2007","journal-title":"Clin Endocrinol"},{"key":"R5-9-20210206","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1155\/2008\/895901","article-title":"Regulation of lymphocyte function by PPARgamma: relevance to thyroid eye disease-related inflammation","volume":"2008","author":"Lehmann","year":"2008","journal-title":"PPAR Res"},{"key":"R6-9-20210206","doi-asserted-by":"crossref","first-page":"38016","DOI":"10.1074\/jbc.M313201200","article-title":"Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I","volume":"279","author":"Entingh-Pearsall","year":"2004","journal-title":"J Biol Chem"},{"key":"R7-9-20210206","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/thy.2007.0028","article-title":"COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy","volume":"17","author":"Vondrichova","year":"2007","journal-title":"Thyroid"},{"key":"R8-9-20210206","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1167\/iovs.05-0605","article-title":"Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy","volume":"46","author":"Feldon","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-9-20210206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2265.2008.03219.x","article-title":"Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy","volume":"69","author":"Chen","year":"2008","journal-title":"Clin Endocrinol"},{"key":"R10-9-20210206","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-9-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","article-title":"Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?","volume":"67","author":"Bednarczuk","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R12-9-20210206","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2265.2007.02942.x","article-title":"Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy","volume":"67","author":"Syed","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R13-9-20210206","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/jc.2007-2190","article-title":"Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23\/T-helper 17 axis extends to thyroid autoimmunity","volume":"93","author":"Huber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-9-20210206","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/sj.gene.6364418","article-title":"Association of NFKB1 -94ins\/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease","volume":"8","author":"Kurylowicz","year":"2007","journal-title":"Genes Immun"},{"key":"R15-9-20210206","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1167\/iovs.07-1433","article-title":"Association of CTLA-4, IL-13 Gene polymorphism with Graves' disease and ophthalmopathy in Chinese children","volume":"49","author":"Chong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-9-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bjo.2007.126789","article-title":"Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy","volume":"92","author":"Boyle","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R17-9-20210206","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/thy.2007.0194","article-title":"The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy","volume":"18","author":"Akaishi","year":"2008","journal-title":"Thyroid"},{"issue":"Suppl 1","key":"R18-9-20210206","first-page":"44","article-title":"Magnetic resonance evaluation of disease activity in Graves' ophthalmopathy: T2-time and signal intensity of extraocular muscles","volume":"13","author":"Majos","year":"2007","journal-title":"Med Sci Monit"},{"key":"R19-9-20210206","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00417-007-0643-0","article-title":"Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves' ophthalmopathy","volume":"246","author":"Chang","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-9-20210206","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MNM.0b013e3282e7d746","article-title":"99mTc(V)-DMSA SPECT for the assessment of disease activity in Graves' ophthalmopathy","volume":"28","author":"Reyhan","year":"2007","journal-title":"Nucl Med Commun"},{"key":"R21-9-20210206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-007-0039-2","article-title":"(99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO)","volume":"31","author":"Sun","year":"2007","journal-title":"Endocrine"},{"key":"R22-9-20210206","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"R23-9-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.1991.1.357","article-title":"Classification of the eye changes of Graves' disease","volume":"1","author":"Wiersinga","year":"1991","journal-title":"Thyroid"},{"key":"R24-9-20210206","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.iop.0000235499.34867.85","article-title":"VISA classification for Graves orbitopathy","volume":"22","author":"Dolman","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R25-9-20210206","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.ophtha.2006.02.060","article-title":"Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy","volume":"113","author":"Bradley","year":"2006","journal-title":"Ophthalmology"},{"key":"R26-9-20210206","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2265.2007.03087.x","article-title":"The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis","volume":"68","author":"Estcourt","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R27-9-20210206","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-6215-9-6","article-title":"Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multicentre, double-masked, factorial randomised controlled trial","volume":"9","author":"Rajendram","year":"2008","journal-title":"Trials"},{"key":"R28-9-20210206","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WNO.0b013e31814a5ef8","article-title":"Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease","volume":"27","author":"Zoumalan","year":"2007","journal-title":"J Neuroophthalmol"},{"key":"R29-9-20210206","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1385\/ENDO:29:3:513","article-title":"New-onset acute heart failure after intravenous glucocorticoid pulse therapy in a patient with Graves' ophthalmopathy","volume":"29","author":"Gursoy","year":"2006","journal-title":"Endocrine"},{"key":"R30-9-20210206","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/thy.2000.10.521","article-title":"Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease","volume":"10","author":"Weissel","year":"2000","journal-title":"Thyroid"},{"key":"R31-9-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.2006.0267","article-title":"Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy","volume":"17","author":"Le Moli","year":"2007","journal-title":"Thyroid"},{"key":"R32-9-20210206","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ophtha.2007.10.028","article-title":"Orbital radiation for Graves ophthalmopathy: a report by the American Academy of Ophthalmology","volume":"115","author":"Bradley","year":"2008","journal-title":"Ophthalmology"},{"key":"R33-9-20210206","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000109275","article-title":"The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence","volume":"222","author":"Wei","year":"2008","journal-title":"Ophthalmologica"},{"key":"R34-9-20210206","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.eye.6701768","article-title":"The effect of etanercept on Graves' ophthalmopathy: a pilot study","volume":"19","author":"Paridaens","year":"2005","journal-title":"Eye"},{"key":"R35-9-20210206","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/jc.2006-2388","article-title":"B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study","volume":"92","author":"El Fassi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-9-20210206","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/eje.1.02119","article-title":"Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression","volume":"154","author":"Salvi","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R37-9-20210206","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/IOP.0b013e3180500d57","article-title":"Rapamycin for treatment of refractory dysthyroid compressive optic neuropathy","volume":"23","author":"Chang","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R38-9-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2265.2007.02845.x","article-title":"Efficacy and safety of orbital decompression in treatment of thyroid-associated ophthalmopathy: long-term follow-up of 78 patients","volume":"67","author":"Jernfors","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R39-9-20210206","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.prs.0000263655.47148.9e","article-title":"Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): experience and progression after more than 3000 operations over 20 years","volume":"120","author":"Richter","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R40-9-20210206","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajo.2007.11.020","article-title":"Results and predictability of fat-removal orbital decompression for disfiguring Graves exophthalmos in an Asian patient population","volume":"145","author":"Wu","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R41-9-20210206","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaapos.2006.10.021","article-title":"Comparison of two different surgical techniques for the treatment of strabismus in dysthyroid ophthalmopathy","volume":"11","author":"Thomas","year":"2007","journal-title":"J AAPOS"},{"key":"R42-9-20210206","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0161-6420(01)00884-3","article-title":"Correction of restricted extraocular muscle motility in surgical management of strabismus in Graves' ophthalmopathy","volume":"109","author":"Nguyen","year":"2002","journal-title":"Ophthalmology"},{"key":"R43-9-20210206","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.ophtha.2006.04.036","article-title":"Intraoperative relaxed muscle positioning technique for strabismus repair in thyroid eye disease","volume":"113","author":"Dal Canto","year":"2006","journal-title":"Ophthalmology"},{"key":"R44-9-20210206","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10792-007-9114-1","article-title":"The surgical management of strabismus with large angle in patients with Graves' ophthalmopathy","volume":"28","author":"Yan","year":"2008","journal-title":"Int Ophthalmol"},{"key":"R45-9-20210206","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R46-9-20210206","first-page":"105","article-title":"Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves' ophthalmopathy","volume":"58","author":"Mysliwiec","year":"2007","journal-title":"Endokrynologia Polska"},{"key":"R47-9-20210206","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/archopht.125.12.1652","article-title":"Oxidative stress change by systemic corticosteroid treatment among patients having active Graves ophthalmopathy","volume":"125","author":"Tsai","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R48-9-20210206","first-page":"104","article-title":"Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy","volume":"52","author":"Mysliwiec","year":"2007","journal-title":"Adv Med Sci"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICU.0b013e3283131557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:04:37Z","timestamp":1786035877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00055735-200811000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0b013e3283131557","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}